Dr. Ahmet Sevimli, MD

  • Deland, FL
  • Nephrologist
NPI1912096629PAC ID3375572621
Medicare services, 2024
2,674
Medicare patients, 2024
660
Part D claims, 2024
826
MIPS score, 2024
94
Hospital affiliations
5
Practice address
350 E New York Ave, Deland, FL 32724
Practice phone
Call (904) 738-2570
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

DaVita Deland Dialysis

Dialysis Center - Independent · Deland, Florida

See all 8 affiliations

Find Dr. Sevimli's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ahmet Sevimli is a nephrologist in Deland, Florida

Dr. Sevimli practices at DaVita Deland Dialysis in Deland, Florida.

Dr. Sevimli's NPI, 1912096629, was assigned on October 12, 2006. Dr. Sevimli graduated from Istanbul University Fom in 1991. Dr. Sevimli holds Florida license ME86956.

NPI and contact details
Medicare PAC ID
3375572621
NPI enumeration date
October 12, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(904) 738-2570
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
61
Medical school graduation
1991

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ahmet Sevimli practices at DaVita Deland Dialysis in Deland, Florida

Dr. Sevimli's primary practice is DaVita Deland Dialysis, at 350 E New York Ave, Deland, FL 32724 in Volusia County. The practice phone is (904) 738-2570.

  • DaVita Deland Dialysis
    350 E New York Ave, Deland, FL 32724 · Volusia CountyPhone(904) 738-2570

Source: Dmand AI Affiliation Data

Dr. Ahmet Sevimli is affiliated with 7 sites of care and 1 medical group

Dr. Sevimli's primary practice is DaVita Deland Dialysis in Deland, Florida. Dr. Sevimli is also affiliated with AdventHealth DeLand. The medical group on file is Florida Kidney and Hypertension Specialists, PA. Dmand AI also links Dr. Sevimli to 4 more hospitals and 1 group practice or clinic, each named with a free account.

See all 8 affiliations for Dr. Sevimli

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Ahmet Sevimli's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sevimli practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
DaVita Deland DialysisAvailable with a free account
+6 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Sevimli practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ahmet Sevimli is one of 917 nephrologists in Florida

Nephrology is Dr. Sevimli's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sevimli is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sevimli's licenses on file in 5 states: Florida, Michigan, Ohio, Pennsylvania and New York.

Specialties and state licenses

  • Nephrology, FloridaPrimaryLicense ME86956 · 2003 to 2027 · taxonomy 207RN0300X
  • Michigan license1997 to 2028
  • Ohio license2003 to 2026
  • Pennsylvania license1995 to 2026
  • New York license2003 to 2006

Clinical focus

Dmand AI lists chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Sevimli treats.

Nephrologists near Dr. Sevimli

Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.

917nephrologists in Florida
5nephrologists in Deland

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ahmet Sevimli billed Medicare for 2,674 services in 2024

CMS data shows 2,674 Medicare services from Dr. Sevimli across 11 procedure codes in 2024, for 660 Medicare patients. Medicare paid $199,889 for them.

Medicare services, 20242,674
Medicare patients660
Paid by Medicare$199,889
Procedure codes11

Dr. Sevimli's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2652024: 1,685536%
Tests and treatments
2023: 672024: 8061103%
Other services
2023: 02024: 183
Lab and pathology
2023: 112024: 0100%

Where Dr. Sevimli's Medicare services took place, 2024

  • In an office1,36351%
  • In a facility1,31149%

Dr. Sevimli compared with the Florida median for nephrologists, 2024

  • Dr. Sevimli
  • Florida median
Medicare services
2,674vs 1,49079% above
Medicare patients
660vs 38771% above
Part D claims
625vs 93433% below

Medians across 882 nephrologists in Florida with Dmand AI profiles that report each measure.

Dr. Sevimli's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sevimli

Need commercial claims for Dr. Sevimli?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sevimli and other nephrologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ahmet Sevimli treated 660 Medicare patients in 2024, average age 75

CMS counts 660 Medicare patients who saw Dr. Sevimli in 2024. The largest group is 75 to 84, with 260 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 3.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sevimli's median patient age at 75, with 50% women.

Medicare patients, 2024660
Average age75
Average risk score3.93
Also on Medicaid30%

Dr. Sevimli's Medicare patients by age, 2024

Dr. Sevimli's Medicare patients by sex, 2024

  • Women30346%
  • Men35754%

Chronic conditions among Dr. Sevimli's Medicare patients, 2024

  1. Chronic kidney disease75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes65%
  5. Heart failure56%
  6. Ischemic heart disease56%
  7. Arthritis51%
  8. Mood disorders46%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sevimli's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women50%
  • Men50%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ahmet Sevimli wrote 826 Medicare Part D claims in 2024

In 2024, Dr. Sevimli wrote 826 Medicare Part D claims for 280 patients. 82% of them were for generic drugs. CMS names the drug for 625 of them, across 18 drugs with 11 or more claims each, at $124,544 in total drug cost. In 2023, CMS named 864 claims across 27 drugs.

Part D claims, 2024826
Drugs named by CMS18
Total drug cost$124,544
Part D patients280

Dr. Sevimli's Part D claims by kind of drug, 2024

  • Generic678 claims82%
  • Brand-name and other148 claims18%

Dr. Sevimli's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Sevimli's Part D claims, 2024

  • Antibiotics2%17 of 826 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 8642024: 62528%

Drugs named by CMS: 18 in 2024, 27 in 2023.

See all prescribing by Dr. Sevimli

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Ahmet Sevimli scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sevimli for performance year 2024, reported as part of a group. Dr. Sevimli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Sevimli's MIPS scores, performance year 2024

  • 94of 100Final score
  • 79.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 77of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find nephrologists like Dr. Sevimli by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ahmet Sevimli received $3,271 in industry payments from 2017 to 2025

CMS Open Payments shows 131 general payments to Dr. Sevimli from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Mallinckrodt Hospital Products Inc. paid the most, $673.

General payments to Dr. Sevimli by program year, 2017 to 2025

General payments to Dr. Sevimli by kind, 2017 to 2025

$3.3Kin total
  • Food and beverage$3,14596%
  • Education$1264%

Companies that paid Dr. Sevimli the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sevimli

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Ahmet Sevimli has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Sevimli, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Sevimli

  1. 2013
    • CMS Stage 1 EHR
  2. Undated
    • ASN Fellow

Source: Dmand AI Professional Profile Data

Dr. Ahmet Sevimli graduated from Istanbul University Fom

Dr. Sevimli graduated from Istanbul University Fom in 1991. Dr. Sevimli is a member of ASN, Nkf and RPA.

  1. Medical schoolIstanbul University Fom
  2. Board certified in internal medicineAmerican Board of Internal Medicine
  3. Board certified in nephrologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Ahmet Sevimli accepts plans from 19 insurance carriers

Dr. Sevimli is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Elevance
  • HCSC
  • Humana
  • Blue Cross Blue Shield of Massachusetts
  • Florida Health Care Plans
  • +11 more carriersWith a free account

Plan types Dr. Sevimli accepts, by number of carriers

  1. PPO12
  2. HMO9
  3. Medicare8
  4. POS5
  5. EPO4

Source: Dmand AI Insurance Network Data

Sources for Dr. Ahmet Sevimli's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ahmet Sevimli

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ahmet Sevimli's NPI number?

Dr. Ahmet Sevimli's NPI number is 1912096629. It was assigned on October 12, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Ahmet Sevimli?

Dr. Ahmet Sevimli is a nephrologist in Deland, Florida. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).

Where does Dr. Ahmet Sevimli practice?

Dr. Sevimli practices at 350 E New York Ave, Deland, FL 32724. Dr. Sevimli's primary practice is DaVita Deland Dialysis in Deland, Florida. Dmand AI also links Dr. Sevimli to 4 hospitals and 1 group practice or clinic.

What is Dr. Ahmet Sevimli's office phone number?

The practice phone on file for Dr. Sevimli is (904) 738-2570.

What is Dr. Ahmet Sevimli's medical license number?

Dr. Sevimli holds Florida license ME86956, one of the licenses on file in 5 states.

Which states has Dr. Ahmet Sevimli been licensed in?

Dmand AI has state licenses on file for Dr. Sevimli in Florida (2003 to 2027), Michigan (1997 to 2028), Ohio (2003 to 2026), Pennsylvania (1995 to 2026) and New York (2003 to 2006).

Which hospitals is Dr. Ahmet Sevimli affiliated with?

Dr. Sevimli is affiliated with AdventHealth DeLand. Dmand AI links Dr. Sevimli to 4 more hospitals.

What medical group is Dr. Ahmet Sevimli part of?

Dr. Sevimli is linked to Florida Kidney and Hypertension Specialists, PA.

Does Dr. Ahmet Sevimli accept Medicare?

Yes. CMS data shows Dr. Sevimli billed Medicare for 2,674 services in 2024, and Dr. Sevimli accepts Medicare assignment.

What is Dr. Ahmet Sevimli's MIPS score?

Dr. Sevimli's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Ahmet Sevimli see?

CMS counts 660 Medicare patients who saw Dr. Sevimli in 2024, with an average age of 75.

Is Dr. Ahmet Sevimli board certified?

Yes. Dr. Sevimli is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. Ahmet Sevimli bill to Medicare?

In 2024, Dr. Sevimli's most billed Medicare services were hospital inpatient care (99232), dialysis (90970) and hospital inpatient care (99233).

Where did Dr. Ahmet Sevimli go to medical school?

Dr. Sevimli graduated from Istanbul University Fom in 1991.

What drugs does Dr. Ahmet Sevimli prescribe most?

In 2024 Medicare Part D data, Dr. Sevimli's most prescribed drugs by claims were Amlodipine Besylate, Lisinopril and Jardiance.

Has Dr. Ahmet Sevimli received payments from drug or device companies?

CMS Open Payments shows $3,271 in general payments to Dr. Sevimli from 22 companies from 2017 to 2025. The largest total came from Mallinckrodt Hospital Products Inc.

How long has Dr. Ahmet Sevimli been practicing?

Dr. Sevimli graduated from medical school in 1991, 35 years ago.

What insurance does Dr. Ahmet Sevimli accept?

Dr. Sevimli is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to nephrology practices?

See nephrologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)